These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6229379)

  • 21. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic beta 1-blockade and control of left ventricular hypertrophy in hypertension.
    Fogari R; Zoppi A; Poletti L; Tettamanti F; Orlandi C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):334-41. PubMed ID: 2957328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of captopril on the hypertrophied heart of essential hypertensive patients.
    Furuno Y; Nakashima Y; Fujita M; Sako R; Kuroiwa A
    J UOEH; 1990 Dec; 12(4):379-87. PubMed ID: 2149616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
    Machnig T; Henneke KH; Engels G; Pongratz G; Schmalzl M; Gellert J; Bachmann K
    Cardiology; 1994; 85(2):101-10. PubMed ID: 7954561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
    Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
    Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertensive hypertrophy of the left ventricle: its regression in hypertensive patients with different profiles of plasma renin activity, treated with enalapril].
    Nogueira JB; Soares Ade O; da Costa JN
    Rev Port Cardiol; 1990 Jun; 9(6):511-6. PubMed ID: 2147377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of yiqi huoxue recipe on cardiac function and ultrastructure in regression of pressure overload-induced myocardial hypertrophy in rats.
    Tong CQ; Di Y; Liu ZQ; Wang YH; He W; Dai EQ
    Chin J Integr Med; 2007 Dec; 13(4):291-6. PubMed ID: 18180895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study.
    Barrios V; Calderón A; Escobar C; Barrios S; Navarro-Cid J; González-Pedel V; Vegazo O; Fernandez R
    J Hypertens; 2007 Sep; 25(9):1967-73. PubMed ID: 17762663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and natural history of left ventricular hypertrophy in hypertension.
    Borhani NO
    J Clin Hypertens; 1987 Mar; 3(1):104-11. PubMed ID: 2952766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C; Michey I; Meani S; Severgnini B; Fusi V; Salerno M; Valerio C; Magrini F; Zanchetti A
    Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-year findings of the Hypertension Detection and Follow-up Program. Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension Detection and Follow-up Program Cooperative Group.
    Hypertension; 1985; 7(1):105-12. PubMed ID: 3156812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
    Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
    Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
    Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of left ventricular hypertrophy by terazosin in hypertensive patients.
    Yasumoto K; Takata M; Yoshida K; Mikawa M; Tomoda F; Sasayama S
    J Hum Hypertens; 1990 Feb; 4(1):13-8. PubMed ID: 1971654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Regression of left ventricular hypertophy in the ECG during antihypertensive treatment: preliminary observations (author's transl)].
    Manegold C; Patzschke U
    Dtsch Med Wochenschr; 1979 Jun; 104(23):846-8. PubMed ID: 156115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circadian blood pressure pattern in patients with treated hypertension and left ventricular hypertrophy.
    Klein W; Zweiker R; Eber B; Dusleag J; Brussee H; Rotman B
    Angiology; 1991 May; 42(5):379-86. PubMed ID: 1827968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the decrease in arterial pressure the sole factor for reduction of left ventricular hypertrophy?
    Schmieder RE; Messerli FH
    Am J Med; 1992 Apr; 92(4B):28S-34S. PubMed ID: 1533746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.